Login / Signup

Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report.

Jana WernerIna ReichenMichael HuberIrene A AbelaMichael WellerIlijas Jelcic
Published in: BMC infectious diseases (2021)
The laboratory and clinical findings as well as the marked improvement after high-dose methylprednisolone therapy suggest a post-infectious, immune-mediated cause of ataxia. This report should make clinicians aware to consider SARS-CoV-2 infection as a potential cause of post-infectious neurological deficits with an atypical clinical presentation and to consider high-dose corticosteroid treatment in case that a post-infectious immune-mediated mechanism is assumed.
Keyphrases